Selected research
Market Outlook & Growth Opportunities
Global Pharmaceutical Manufacturing and Processing Equipment Market Outlook and Growth Opportunities 2026
Market perspective
The global Pharmaceutical Manufacturing and Processing Equipment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Pharmaceutical Manufacturing and Processing Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pharmaceutical Manufacturing and Processing Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pharmaceutical Manufacturing and Processing Equipment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Pharmaceutical Manufacturing and Processing Equipment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Pharmaceutical Manufacturing and Processing Equipment market include Syntegon, IMA, GEA, Truking, Uhlmann, Marchesini, Tofflon, Glatt and Bausch + Stroebel, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Pharmaceutical Manufacturing and Processing Equipment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pharmaceutical Manufacturing and Processing Equipment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pharmaceutical Manufacturing and Processing Equipment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical Manufacturing and Processing Equipment market.
Pharmaceutical Manufacturing and Processing Equipment Segment by Company
Syntegon
IMA
GEA
Truking
Uhlmann
Marchesini
Tofflon
Glatt
Bausch + Stroebel
ACG
Thermo Fisher
Sartorius
Agilent Technologies
L.B. Bohle
Fette
KORSCH
Coperion
Bruker
Danaher Corp
Shimadzu
NETZSCH
Mettler-Toledo
Gardner Denver
CEIA
Anritsu
Gericke
AERZEN
O'Hara Technologies Inc
Pharmaceutical Manufacturing and Processing Equipment Segment by Type
Filling
Blowers
Coaters
Dryers
Granulators
Metal Detectors
Sifters
Process analytical Technology Equipment
Tablet Press(For Solid dosage)
Other(Feeder(For Solid dosage) etc.)
Pharmaceutical Manufacturing and Processing Equipment Segment by Formulation
Tablets
Capsules
Injectable
Powders
Sprays
Others
Pharmaceutical Manufacturing and Processing Equipment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Pharmaceutical Manufacturing and Processing Equipment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Pharmaceutical Manufacturing and Processing Equipment key companies, revenue, market share, and recent developments.
3. To split the Pharmaceutical Manufacturing and Processing Equipment breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Pharmaceutical Manufacturing and Processing Equipment market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pharmaceutical Manufacturing and Processing Equipment significant trends, drivers, influence factors in global and regions.
6. To analyze Pharmaceutical Manufacturing and Processing Equipment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Manufacturing and Processing Equipment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Manufacturing and Processing Equipment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Manufacturing and Processing Equipment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical Manufacturing and Processing Equipment industry.
Chapter 3: Detailed analysis of Pharmaceutical Manufacturing and Processing Equipment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Pharmaceutical Manufacturing and Processing Equipment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Pharmaceutical Manufacturing and Processing Equipment in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Filling
- Blowers
- Coaters
- Dryers
- Granulators
- Metal Detectors
- Sifters
- Process analytical Technology Equipment
- Tablet Press(For Solid dosage)
- Other(Feeder(For Solid dosage) etc.)
Applications
- Tablets
- Capsules
- Injectable
- Powders
- Sprays
- Others
Companies covered
- Syntegon
- IMA
- GEA
- Truking
- Uhlmann
- Marchesini
- Tofflon
- Glatt
- Bausch + Stroebel
- ACG
- Thermo Fisher
- Sartorius
- Agilent Technologies
- L.B. Bohle
- Fette
- KORSCH
- Coperion
- Bruker
- Danaher Corp
- Shimadzu
- NETZSCH
- Mettler-Toledo
- Gardner Denver
- CEIA
- Anritsu
- Gericke
- AERZEN
- O'Hara Technologies Inc
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pharmaceutical Manufacturing and Processing Equipment Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pharmaceutical Manufacturing and Processing Equipment Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Pharmaceutical Manufacturing and Processing Equipment Market Dynamics
- 2.1 Pharmaceutical Manufacturing and Processing Equipment Industry Trends
- 2.2 Pharmaceutical Manufacturing and Processing Equipment Industry Drivers
- 2.3 Pharmaceutical Manufacturing and Processing Equipment Industry Opportunities and Challenges
- 2.4 Pharmaceutical Manufacturing and Processing Equipment Industry Restraints
3 Pharmaceutical Manufacturing and Processing Equipment Market by Company
- 3.1 Global Pharmaceutical Manufacturing and Processing Equipment Company Revenue Ranking in 2025
- 3.2 Global Pharmaceutical Manufacturing and Processing Equipment Revenue by Company (2021-2026)
- 3.3 Global Pharmaceutical Manufacturing and Processing Equipment Company Ranking (2024-2026)
- 3.4 Global Pharmaceutical Manufacturing and Processing Equipment Company Manufacturing Base and Headquarters
- 3.5 Global Pharmaceutical Manufacturing and Processing Equipment Company Product Type and Application
- 3.6 Global Pharmaceutical Manufacturing and Processing Equipment Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Pharmaceutical Manufacturing and Processing Equipment Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Pharmaceutical Manufacturing and Processing Equipment Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical Manufacturing and Processing Equipment Market by Type
- 4.1 Pharmaceutical Manufacturing and Processing Equipment Type Introduction
- 4.1.1 Filling
- 4.1.2 Blowers
- 4.1.3 Coaters
- 4.1.4 Dryers
- 4.1.5 Granulators
- 4.1.6 Metal Detectors
- 4.1.7 Sifters
- 4.1.8 Process analytical Technology Equipment
- 4.1.9 Tablet Press(For Solid dosage)
- 4.1.10 Other(Feeder(For Solid dosage) etc.)
- 4.2 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Type
- 4.2.1 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Type (2021-2032)
- 4.2.3 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type (2021-2032)
5 Pharmaceutical Manufacturing and Processing Equipment Market by Application
- 5.1 Pharmaceutical Manufacturing and Processing Equipment Application Introduction
- 5.1.1 Tablets
- 5.1.2 Capsules
- 5.1.3 Injectable
- 5.1.4 Powders
- 5.1.5 Sprays
- 5.1.6 Others
- 5.2 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Application
- 5.2.1 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Application (2021-2032)
- 5.2.3 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application (2021-2032)
6 Pharmaceutical Manufacturing and Processing Equipment Regional Value Analysis
- 6.1 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Region (2021-2032)
- 6.2.1 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Region: 2021-2026
- 6.2.2 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharmaceutical Manufacturing and Processing Equipment Sales Value (2021-2032)
- 6.3.2 North America Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Pharmaceutical Manufacturing and Processing Equipment Sales Value (2021-2032)
- 6.4.2 Europe Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Pharmaceutical Manufacturing and Processing Equipment Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Pharmaceutical Manufacturing and Processing Equipment Sales Value (2021-2032)
- 6.6.2 South America Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Pharmaceutical Manufacturing and Processing Equipment Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical Manufacturing and Processing Equipment Country-level Value Analysis
- 7.1 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Country (2021-2032)
- 7.2.1 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Country (2021-2026)
- 7.2.2 Global Pharmaceutical Manufacturing and Processing Equipment Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.7.2 France Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.14.2 China Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.17.2 India Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Pharmaceutical Manufacturing and Processing Equipment Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Pharmaceutical Manufacturing and Processing Equipment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Syntegon
- 8.1.1 Syntegon Company Information
- 8.1.2 Syntegon Business Overview
- 8.1.3 Syntegon Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.1.4 Syntegon Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.1.5 Syntegon Recent Developments
- 8.2 IMA
- 8.2.1 IMA Company Information
- 8.2.2 IMA Business Overview
- 8.2.3 IMA Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.2.4 IMA Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.2.5 IMA Recent Developments
- 8.3 GEA
- 8.3.1 GEA Company Information
- 8.3.2 GEA Business Overview
- 8.3.3 GEA Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.3.4 GEA Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.3.5 GEA Recent Developments
- 8.4 Truking
- 8.4.1 Truking Company Information
- 8.4.2 Truking Business Overview
- 8.4.3 Truking Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.4.4 Truking Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.4.5 Truking Recent Developments
- 8.5 Uhlmann
- 8.5.1 Uhlmann Company Information
- 8.5.2 Uhlmann Business Overview
- 8.5.3 Uhlmann Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.5.4 Uhlmann Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.5.5 Uhlmann Recent Developments
- 8.6 Marchesini
- 8.6.1 Marchesini Company Information
- 8.6.2 Marchesini Business Overview
- 8.6.3 Marchesini Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.6.4 Marchesini Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.6.5 Marchesini Recent Developments
- 8.7 Tofflon
- 8.7.1 Tofflon Company Information
- 8.7.2 Tofflon Business Overview
- 8.7.3 Tofflon Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.7.4 Tofflon Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.7.5 Tofflon Recent Developments
- 8.8 Glatt
- 8.8.1 Glatt Company Information
- 8.8.2 Glatt Business Overview
- 8.8.3 Glatt Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.8.4 Glatt Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.8.5 Glatt Recent Developments
- 8.9 Bausch + Stroebel
- 8.9.1 Bausch + Stroebel Company Information
- 8.9.2 Bausch + Stroebel Business Overview
- 8.9.3 Bausch + Stroebel Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.9.4 Bausch + Stroebel Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.9.5 Bausch + Stroebel Recent Developments
- 8.10 ACG
- 8.10.1 ACG Company Information
- 8.10.2 ACG Business Overview
- 8.10.3 ACG Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.10.4 ACG Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.10.5 ACG Recent Developments
- 8.11 Thermo Fisher
- 8.11.1 Thermo Fisher Company Information
- 8.11.2 Thermo Fisher Business Overview
- 8.11.3 Thermo Fisher Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.11.4 Thermo Fisher Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.11.5 Thermo Fisher Recent Developments
- 8.12 Sartorius
- 8.12.1 Sartorius Company Information
- 8.12.2 Sartorius Business Overview
- 8.12.3 Sartorius Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.12.4 Sartorius Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.12.5 Sartorius Recent Developments
- 8.13 Agilent Technologies
- 8.13.1 Agilent Technologies Company Information
- 8.13.2 Agilent Technologies Business Overview
- 8.13.3 Agilent Technologies Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.13.4 Agilent Technologies Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.13.5 Agilent Technologies Recent Developments
- 8.14 L.B. Bohle
- 8.14.1 L.B. Bohle Company Information
- 8.14.2 L.B. Bohle Business Overview
- 8.14.3 L.B. Bohle Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.14.4 L.B. Bohle Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.14.5 L.B. Bohle Recent Developments
- 8.15 Fette
- 8.15.1 Fette Company Information
- 8.15.2 Fette Business Overview
- 8.15.3 Fette Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.15.4 Fette Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.15.5 Fette Recent Developments
- 8.16 KORSCH
- 8.16.1 KORSCH Company Information
- 8.16.2 KORSCH Business Overview
- 8.16.3 KORSCH Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.16.4 KORSCH Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.16.5 KORSCH Recent Developments
- 8.17 Coperion
- 8.17.1 Coperion Company Information
- 8.17.2 Coperion Business Overview
- 8.17.3 Coperion Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.17.4 Coperion Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.17.5 Coperion Recent Developments
- 8.18 Bruker
- 8.18.1 Bruker Company Information
- 8.18.2 Bruker Business Overview
- 8.18.3 Bruker Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.18.4 Bruker Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.18.5 Bruker Recent Developments
- 8.19 Danaher Corp
- 8.19.1 Danaher Corp Company Information
- 8.19.2 Danaher Corp Business Overview
- 8.19.3 Danaher Corp Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.19.4 Danaher Corp Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.19.5 Danaher Corp Recent Developments
- 8.20 Shimadzu
- 8.20.1 Shimadzu Company Information
- 8.20.2 Shimadzu Business Overview
- 8.20.3 Shimadzu Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.20.4 Shimadzu Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.20.5 Shimadzu Recent Developments
- 8.21 NETZSCH
- 8.21.1 NETZSCH Company Information
- 8.21.2 NETZSCH Business Overview
- 8.21.3 NETZSCH Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.21.4 NETZSCH Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.21.5 NETZSCH Recent Developments
- 8.22 Mettler-Toledo
- 8.22.1 Mettler-Toledo Company Information
- 8.22.2 Mettler-Toledo Business Overview
- 8.22.3 Mettler-Toledo Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.22.4 Mettler-Toledo Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.22.5 Mettler-Toledo Recent Developments
- 8.23 Gardner Denver
- 8.23.1 Gardner Denver Company Information
- 8.23.2 Gardner Denver Business Overview
- 8.23.3 Gardner Denver Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.23.4 Gardner Denver Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.23.5 Gardner Denver Recent Developments
- 8.24 CEIA
- 8.24.1 CEIA Company Information
- 8.24.2 CEIA Business Overview
- 8.24.3 CEIA Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.24.4 CEIA Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.24.5 CEIA Recent Developments
- 8.25 Anritsu
- 8.25.1 Anritsu Company Information
- 8.25.2 Anritsu Business Overview
- 8.25.3 Anritsu Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.25.4 Anritsu Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.25.5 Anritsu Recent Developments
- 8.26 Gericke
- 8.26.1 Gericke Company Information
- 8.26.2 Gericke Business Overview
- 8.26.3 Gericke Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.26.4 Gericke Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.26.5 Gericke Recent Developments
- 8.27 AERZEN
- 8.27.1 AERZEN Company Information
- 8.27.2 AERZEN Business Overview
- 8.27.3 AERZEN Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.27.4 AERZEN Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.27.5 AERZEN Recent Developments
- 8.28 O'Hara Technologies Inc
- 8.28.1 O'Hara Technologies Inc Company Information
- 8.28.2 O'Hara Technologies Inc Business Overview
- 8.28.3 O'Hara Technologies Inc Pharmaceutical Manufacturing and Processing Equipment Revenue and Gross Margin (2021-2026)
- 8.28.4 O'Hara Technologies Inc Pharmaceutical Manufacturing and Processing Equipment Product Portfolio
- 8.28.5 O'Hara Technologies Inc Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst